EcoDrugPlus

Coagulation Factor Xi-Like

Ensembl ID : ENSAPOG00000002609
Gene Symbol: LOC110968374
2 Cross references
203 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSAPOG00000005718
Gene Symbol: CCDC6
3 Cross references
208 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSAPOG00000010590
Gene Symbol: CSF1R
3 Cross references
207 Possible Orthologues:

Complement C1r-A Subcomponent-Like

Ensembl ID : ENSAPOG00000010394
Gene Symbol: LOC110965725
2 Cross references
177 Possible Orthologues:

Complement C5

Ensembl ID : ENSAPOG00000018178
Gene Symbol: C5
2 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSAPOG00000021142
Gene Symbol: CRHR1
3 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSAPOG00000009851
Gene Symbol: CCND1
3 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSAPOG00000024075
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSAPOG00000007495
Gene Symbol: CDK2
3 Cross references
203 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSAPOG00000000187
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSAPOG00000018606
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSAPOG00000011370
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).